by Jordana Choucair | Dec 16, 2022 | Life Sciences
AbbVie Inc is leaving the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Innovation Organization, two of the most influential pharmaceutical trade groups. The pharmaceutical giant’s move comes as provisions in the Inflation...
by Jordana Choucair | Dec 13, 2022 | Life Sciences
The Supreme Court denied a request to block California’s recently passed ban on flavored tobacco products. Major tobacco companies including R.J. Reynolds Tobacco Company, the Santa Fe Natural Tobacco Company, and Modoral Brands Inc. requested an injunction last...
by Jordana Choucair | Dec 13, 2022 | Life Sciences
A new study shows COVID-19 vaccines have kept more than 18 million people out of the hospital and saved more than 3 million lives. Without the vaccines, the nation would have had 1.5 times more infections, 3.8 times more hospitalizations and 4.1 times more deaths than...
by Jordana Choucair | Dec 9, 2022 | Life Sciences
The Mark Cuban Cost Plus Drug Co. and the Purchaser Business Group on Health’s EmansaRx jointly launched EmansaRx Plus, a pharmacy benefit manager (PBM) majority-owned by the business group that supplements employers’ existing drug benefits. EmansaRx Plus...
by Jordana Choucair | Dec 9, 2022 | Life Sciences
The Food and Drug Administration (FDA) authorized updated COVID-19 shots from Pfizer and Moderna that target the omicron variant for children as young as six months. Children between 6 months and 5 years old who received the Moderna primary series can receive the...
by Jordana Choucair | Dec 8, 2022 | Life Sciences
Pfizer and Moderna announced that the commercial prices of their COVID-19 vaccines will likely be between $82 and $130 per dose. The cost is approximately three to four times what the federal government has paid. The Biden administration has started to prepare for the...
Recent Comments